@ThinkingUSD I had neck and lower back pain due to accident (bulging discs and joint deterioration) only thing that worked, having tried everything except surgery, was stem cell injections. DM if you’d like more info on my experiences.
🚨 BREAKING NEWS: RFK Jr. says ~14 of 19 banned peptides can be legally compounded again by US pharmacies within a few weeks. This will ensure Americans are getting "a good product… from ethical suppliers" vs. black market drug dealers that provide "substandard product" with serious safety risks.
The 19 compounds on FDA’s Category 2 compounding safety list include:
• BPC-157
• Cathelicidin LL-37
• Emideltide (DSIP)
• Epitalon
• GHK-Cu (injectable)
• GHRP-2 (injectable/nasal)
• GHRP-6
• Ipamorelin acetate
• Kisspeptin-10
• KPV
• Melanotan II
• PEG-MGF (pegylated Mechano Growth Factor)
• MOTS-C
• Semax
• Thymosin beta-4 fragment (LKKTETQ)
• AOD-9604
• CJC-1295
• Selank acetate (TP-7)
• Thymosin-alpha 1 (Ta1)
The five least likely to be legalized in a policy shift would be those with the most troubling safety signals or the weakest human data — for example: Melanotan II, Cathelicidin LL-37, GHRP-2, Ipamorelin acetate, and CJC-1295 — because of documented serious adverse events or other red flags in FDA’s risk assessment.
My guy @0x_Arcana just dropped the most comprehensive report on Keeta and its potential to own the rails that bridge TradFi and onchain
This is a deep review and goes into the details on the technical aspects that have kept me so excited since I first stumbled on Keeta
$KTA
Today marks the beginning of a new era.
Keeta Network mainnet is live.
A global system for value transfer, built for banks, governments, and people everywhere.
$KTA
A few strong views on the Robotics Industry:
1 - General Purpose Robotics will be much larger than Specialized Robotics
2 - Vertically integrated (AI + hardware) companies have huge edge
3 - In the short term, the best robot models will be derived from real robot data. In the long term, they will come from simulated data
4 - The biggest companies will be US companies that understand how to bridge the talent and infrastructure from Asia
5 - Early distribution is critical